PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced results from its second pivotal, Phase 3 clinical trial assessing the safety and efficacy of EXPAREL® ...
The use of intercostal nerve block (ICNB) for thoracic surgery can reduce pain in the first 24 hours after surgery and decrease opioid use, according to a systematic review and meta-analysis, ...
Effective pain management is a cornerstone of postoperative care in cardiac surgery. Advances in regional anaesthesia, particularly ultrasound‐guided techniques, have markedly improved the precision ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced results from its second pivotal, Phase 3 clinical trial assessing the safety and efficacy of EXPAREL ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback